IGF1 and cancer: Results from in vivo carcinogenesis models and epidemiological studies indicate that high levels of circulating IGF-1 are associated with increased risk and progression of several common cancers, including breast [3]–[7], prostate [8]–[11], colorectal [12]–[15], and ovarian cancer [16]–[17] among others.